INVO Bioscience Secures Regulatory Approval to Commercialize Infertility Treatment in Thailand — Shares Climb

MT Newswires 2021

All news about INVO BIOSCIENCE, INC.
Sales 2021 1,32 M

Net income 2021 -9,28 M

Net Debt 2021

P/E ratio 2021 -3,48x
Yield 2021
Capitalization 36,1 M
36,1 M
Capi. / Sales 2021 27,5x
Capi. / Sales 2022 5,10x
Nbr of Employees 10
Free-Float 90,0%
Chart INVO BIOSCIENCE, INC.

Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.



Period :
Day
Week

INVO Bioscience, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends INVO BIOSCIENCE, INC.

Short Term Mid-Term Long Term
Trends Bearish Bearish Bearish

Income Statement Evolution

Sell

Buy

Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 3,08 $
Average target price 5,00 $
Spread / Average Target 62,3%